福安药业：子公司收到注射用硫酸艾沙康唑药品注册证书

Core Viewpoint - Fuan Pharmaceutical has received a drug registration certificate for injectable isavuconazole from the National Medical Products Administration, indicating a significant advancement in its product offerings for treating invasive fungal infections [1] Company Summary - Fuan Pharmaceutical's wholly-owned subsidiary, Hubei Renmin Pharmaceutical Co., Ltd., is responsible for the newly registered injectable isavuconazole [1] - The injectable isavuconazole is indicated for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis [1]